Bridgefront Capital’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-5,381
Closed -$827K – 578
2026
Q1
$827K Buy
+5,381
New +$730K 0.21% 156
2025
Q3
– Sell
-4,001
Closed -$570K – 647
2025
Q2
$570K Buy
+4,001
New +$567K 0.15% 249
2024
Q3
– Sell
-1,888
Closed -$262K – 579
2024
Q2
$262K Buy
1,888
+420
+29% +$57.9K 0.11% 336
2024
Q1
$203K Buy
+1,468
New +$176K 0.15% 314
2021
Q4
– Sell
-2,289
Closed -$266K – 346
2021
Q3
$266K Sell
2,289
-395
-15% -$49.5K 0.28% 163
2021
Q2
$323K Buy
+2,684
New +$318K 0.12% 323

Other funds holding DVA

Bridgefront Capital's DVA Position: Q2 2026 in Review

Bridgefront Capital sold out of DaVita (DVA) in Q2 2026, closing a stake of 5,381 shares — an estimated $827K sold.

Bridgefront Capital first reported a position in DVA in Q2 2021 and held it in 6 quarters. The position peaked at $827K in Q1 2026. 631 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • Bridgefront Capital reported no remaining DaVita position as of Q2 2026 after selling out during the quarter.
  • Bridgefront Capital sold 5,381 DaVita shares in Q2 2026, an estimated $827K.
  • Bridgefront Capital first reported a position in DaVita in Q2 2021 and held it in 6 quarters.
  • Bridgefront Capital's DaVita position peaked at $827K in Q1 2026.
  • 631 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.